New York, NY, United States of America

Ann Reese Comfort

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ann Reese Comfort. Retrieved from https://idiyas.com/inventor/ann-reese-comfort

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ann Reese Comfort: Innovator in Pharmaceutical Formulations

Introduction

Ann Reese Comfort is a notable inventor based in New York, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of solid dosage forms. Her innovative work has led to the development of a unique patent that addresses important aspects of drug delivery.

Latest Patents

Ann Reese Comfort holds a patent for an immediate release formulation of 4-methyl-3-4[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-YL)-3-(trifluoromethyl)phenyl] benzamide. This patent describes a solid dosage form of nilotinib that includes a core made up of the active ingredient or a pharmaceutically acceptable salt, along with excipients. Additionally, the formulation features at least one polymer that coats the core, which delays the disintegration of the solid dosage form, enhancing its effectiveness.

Career Highlights

Ann is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to leverage her expertise in pharmaceutical formulations, contributing to the advancement of innovative drug delivery systems. Her work is instrumental in improving patient outcomes through effective medication administration.

Collaborations

Throughout her career, Ann has collaborated with

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…